This study evaluated the potential reproductive toxicity of phenol in a rat two-generation reproduction study, which included additional study endpoints, such as sperm count and motility, developmental landmarks, histological evaluation of suspect target organs (liver, kidneys, spleen, and thymus), weanling reproductive organ weights, and an immunotoxicity screening plaque assay. Phenol was administered to 30 Sprague-Dawley rats/sex/group in the drinking water at concentrations of 0, 200, 1000, or 5000 ppm. Parental (P 1 ) animals were treated for 10 weeks prior to mating, during mating, gestation, lactation, and until sacri ce. The F 1 generation (P 1 offspring) was treated using a similar regimen, while the F 2 generation was not treated. After mating, 10 P 1 males/group were evaluated using standard clinical pathology parameters and an immunotoxicity screening plaque assay. Signi cant reductions in water and food consumption were observed in the 5000-ppm group in both generations; corollary reductions in body weight/ body weight gain were also observed. Mating performance and fertility in both generations were similar to controls, and no adverse effects on vaginal cytology or male reproductive function were observed. Vaginal opening and preputial separation were delayed in the 5000-ppm group, and were considered to be secondary to the reduction in F 1 body weight. Litter survival of both generations was reduced in the 5000-ppm group. Absolute uterus and prostate weights were decreased in the F 1 generation at all dose levels; however, no underlying pathology was observed and there was no functional de cit in reproductive performance. Therefore, these ndings were not considered to be adverse. No evidence of immunotoxicity was noted in the 5000-ppm group. The effects noted at the high concentration were presumed to be associated with avor aversion to phenol in the drinking water. Based on a comprehensive examination of all parameters, the no-observable-adverse-effect level (NOAEL) for reproductive toxicity of phenol administered in drinking water to rats is 1000 ppm. The corresponding daily intake of phenol for an adult rat at the NOAEL of 1000 ppm is equivalent to about 70 mg/kg/day for males and 93 mg/kg/day for females.
in drinking water across ve generations and no effects during exposure to 5000 ppm across three generations. At 8000 ppm and higher many offspring did not survive; however, the adverse effects on survival may have been secondary to maternal toxicity. Although this study spanned ve generations, it was not considered adequately documented in that it did not include conventional endpoints necessary for the assessment of the potential for phenol to cause adverse reproductive effects. The reported two-generation reproduction study of phenol was conducted as part of a negotiated consent agreement between United States Environmental Protection Agency (USEPA) and the Phenol Panel of the Chemical Manufacturers Association.
As such, the current study was designed to evaluate the potential of phenol to alter fertility, including male reproductive function (sperm count, motility, and morphology), and female cyclicity (vaginal cytology), pregnancy, lactation, and development of the offspring following oral (drinking water) administration of phenol through two generations of Sprague-Dawley rats. Our study was modeled after the revised draft testing guidelines set forth under Of ce of Prevention, Pesticides and Toxic Substances (OPPTS) (870.3800), which combines the testing guidance and requirements of OPPTS, Of ce of Pesticide Program (OPP), and Organization for Economic Cooperation and Development (OECD) . In addition, the potential immunotoxicity of phenol was examined in male rats following 13 weeks of phenol exposure, via a plaque assay, because variable results on the immune system have been reported. Hsieh et al. (1992) reported that mice administered 95 ppm phenol in drinking water for 4 weeks had suppressed stimulation of cultured splenic lymphocytes by mitogens, and that 20 and 95 ppm suppressed antibody production to sheep red blood cells and serum antibody levels. On the other hand, Aranyi (1986) reported that a single 3hour inhalation exposure of mice to 5 ppm phenol had no effect on susceptibility to experimentally induced streptococcus infection, or to pulmonary bactericidal activity to inhaled Klebsiella pneumoniae. Hsieh et al. (1992) also found that administration of 5, 20, and 95 ppm phenol in drinking water caused signi cant reductions in red blood cell counts in mice exposed to phenol for 4 weeks. Therefore, prior to immunotoxicity screening and after 13 weeks of phenol exposure, blood was collected from the male rats and standard clinical chemistry and hematology endpoints were evaluated.
Finally, Berman et al. (1995) reported hepatocellular necrosis after a single oral (bolus gavage) dose of 40 mg/kg/day of phenol and an increase in kidney lesions following 14 days of exposure to 40 mg/kg/day; these lesions were attributed to vascular stasis in both liver and kidneys. Thus, histological examination of potential target organs (kidney, liver, thymus, and spleen) was included in this study.
METHODS

Test Substance and Formulations
Pure 100% phenol, a white solid (Lot number 112796; batch number 102596), was supplied by Harrell Industries, Rock Hill, SC, and was received and stored in amber glass bottles blanketed with nitrogen to minimize oxidation/degradation of phenol. Phenol was administered in the drinking water; the formulations were prepared weekly at 0, 200, 1000, and 5000 ppm. To conrm the concentration of phenol in the drinking water as well as determine stability, aliquots of the test formulations were analyzed using reverse-phase high performance liquid chromatography (HPLC) with ultraviolet (UV) detection at 254 nm. The HPLC analysis conditions were: Supelcosil column LC-18, 5 micron, 4.6 mm £ 25 cm with a mobile phase of 60% (1:49 acetic acid/water), 40% acetonitrile and a ow rate of 1.0 ml/min. The injection volume was 50 ¹l and the retention time was approximately 5.5 minutes. Each formulation was analyzed in duplicate by preparing two separate samples, and analysis was performed during weeks 1, 3, 5, 7 and every other month thereafter. Samples were considered to be within an acceptable range if they were within 3% of the target concentrations. In addition, stability tests were performed on samples stored at room temperature for up to 14 days.
Animals and Husbandry
Sprague-Dawley rats (Taconic Farms, Germantown, NY) were 4 weeks old when received. Rats were quarantined for 12 days and then examined for suitability to use as test animals. Prior to mating, all rats were housed singly in stainless steel wire mesh cages over absorbent cageboard or paper. During mating, animals were housed in polycarbonate cages with corncob bedding. After mating, males were returned to their home cages, whereas females and their litters remained in polycarbonate cages during gestation and lactation. Weanlings were moved to stainless steel cages. Animal rooms were maintained at 20 ± to 25 ± C and 30% to 70% relative humidity. Lights were cycled 12 hours on and 12 hours off. All animals received Purina Certi ed Rodent Meal #5002 (PMI Feeds Inc., St. Louis) and City of Chicago municipal tap water or phenol formulated in tap water ad libitum. Use of animals in this study was in accordance with all applicable animal welfare guidelines and regulations (USDA; CFR 91A; NRC, 1996) .
Experimental Design
Parental (P 1 ) rats randomly assigned to four groups of 30 animals per sex per group received 0, 200, 1000, or 5000 ppm phenol, respectively, in the drinking water for 10 weeks prior to mating, during a 2-week mating period, through gestation, lactation, and until sacri ce. Doses were based on a reproductive probe study (exposure included 4 weeks prior to mating, during mating, gestation, lactation, and 3 weeks post weaning) in which decreased drinking water, food consumption, and body weight gain were observed at 5000 and 7500 ppm (data not shown). Treatment of the rst generation of P 1 rats began at approximately 6 weeks of age.
Parental generation (P 1 ) rats from the same dose level were mated one male with one female at approximately 10 weeks of age. Daily vaginal lavage specimens were taken from each female rat 3 weeks prior to mating to ensure and evaluate cyclicity, and during mating until a sperm-positive smear was detected. The target number of subjects was 25 sperm-positive dams/group to produce the rst generation (F 1 ). The day a spermpositive smear was observed was designated gestation day 0. Females were allowed a natural parturition. On the day of observed parturition (postnatal day 0), the pups were counted, sexed, and examined grossly for morphological anomalies.
On postnatal day 4, the rst generation (F 1 ) litters were culled to four per sex per litter. Pups were weaned on postnatal day 22, and selected F 1 animals (at least one per sex per litter) were single-housed and administered the same concentration of phenol in water, as their parents, for 11 weeks prior to mating. F 1 adults were then paired one male and one female from the same dose group for mating, with care taken to avoid sibling matings. Administration of the appropriate drinking water formulation continued through mating, gestation, lactation, weaning, and until sacri ce.
Second generation (F 2 ) litters were culled to four pups per sex per litter on postnatal day 4. The F 2 generation was not intentionally exposed to the test substance in the drinking water. All F 2 pups and F 1 sires and dams were sacri ced after weaning.
When the P 1 males were no longer needed for mating, 10 P 1 males/group were randomly assigned to undergo clinical pathology evaluation and immunotoxicity screening. In addition, ve extra male rats, which were not assigned to study groups, were randomly selected as positive controls for the immunotoxicity screening.
Clinical Observations
All rats were examined at least once each day for morbidity and mortality. During gestation, dams were examined twice each day for evidence of parturition. Each rat also received a weekly hand-held clinical observation, which was recorded by electronic data capture using LABCAT (IPA, Inc., Princeton, NJ, version 4.64). The gross external appearance of each pup was evaluated on the day of birth (postnatal day 0).
For all F 1 female pups selected to produce the F 2 generation, vaginal patency was checked on postnatal days 28 to 45. Selected F 1 male pups were checked for preputial separation on postnatal days 34 to 55.
Body Weight, Body Weight Gain, and Food and Water Consumption
Water and food consumption for all rats was measured weekly prior to mating, but was not measured during cohabitation. After mating, water and food consumption of male rats was measured weekly, whereas for females it was measured on gestation days 0, 7, 14, and 20, and on postnatal days 0, 4, 7, 14, and 21.
All animals were weighed weekly prior to mating. After mating, males were weighed weekly until sacri ce. Dams were weighed on gestation days 0, 7, 14, and 20, and dams and pups were weighed on postnatal days 0, 4, 7, 14, and 21. The average pup weight was calculated per litter and per group. Body weight gains were calculated for all animals, except pups during lactation. All P 1 and weaned F 1 body weights, water and food consumption data were collected, while body weight gains and consumption values were calculated using LABCAT. In addition, body weights were recorded on the day of observed vaginal patency and preputial separation in the F 1 generation.
Vaginal Cytology
Vaginal lavage specimens were evaluated from all females (P 1 and F 1 ) for 3 weeks prior to mating to evaluate cyclicity. Evaluations of vaginal cytology were continued through mating until the presence of sperm or a vaginal plug was observed in situ as an indication of mating. In addition, specimens collected by vaginal lavage were evaluated prior to necropsy to determine the stage of the estrus cycle for each animal at termination.
Clinical Pathology
After mating, 10 P 1 males/group were randomly assigned to undergo clinical pathology evaluation and immunotoxicity screening. Blood samples were collected from selected rats via the retro-orbital plexus after 13 weeks of treatment. Rats were fasted for approximately 18 hours before blood collection, and were rendered unconscious by placing them in an atmosphere of 70% CO 2 /30% air. The following serum chemistry parameters were evaluated: albumin, globulin, albumin/globulin ratio, total protein, blood urea nitrogen, glucose, alkaline phosphatase, total bilirubin, aspartate aminotransferase, alanine aminotransferase, chloride, calcium, phosphorus , sodium, potassium, creatinine, cholesterol, and triglycerides. Hematological parameters evaluated consisted of hematocrit, hemoglobin, total erythrocyte count, total leukocyte count, differential leukocyte count (percent and absolute), mean corpuscular volume, mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, red cell morphology and platelet count. Hematology and serum chemistry analyses were performed using a Baker System 9000 Hematology Analyzer and a Beckman Synchron CX5 analyzer, respectively.
Immunotoxicity Screening
A modi ed plaque assay based on the original work of Cunningham and Szenberg (1968) was used to assess the induction of splenic antibody-forming cells (AFC) secreting IgM antibody speci c for sheep red blood cells (SRBC), a T-dependent antigen. After mating, 10 male rats/group were immunized once by intravenous injection of washed SRBC (Colorado Serum Co.). The animals were euthanized by CO 2 asphyxiation, the spleens were removed, weighed, and single-cell suspensions of splenocytes prepared in cell culture medium. Spleen cells were suspended in RPMI 1640 with HEPES culture medium (BioWhittaker, Walkersville, MD) supplemented with 10 ug/ml gentamicin and 2 mM L-glutamine. Spleen cell density was determined by Coulter count and viability was determined by trypan blue exclusion. Tubes containing agarose/DEAE/dextran, splenocytes, fresh SRBC, and guinea pig complement were prepared and plaque-forming cells were subsequently enumerated. Positive-control rats received daily intraperitoneal (IP) injections of cyclophosphamide (20 mg/kg/day) for 4 days prior to assay. All AFC animals received approximately 2 £ 10 8 SRBC by intravenous (IV) injection in a 0.5 ml volume 4 days prior to assay.
Postmortem Observations
At least 20 rats per sex per group in the P 1 and F 1 generations were subjected to a gross necropsy, which included examination of the external surface and pleural, peritoneal, and cranial cavities. F 2 rats and culled pups were euthanized and discarded without necropsy. The following organs were weighed at necropsy: uterus, ovaries with oviducts, testes, epididymides (left, total, and left caudal), prostate, brain, liver, kidneys, adrenals, spleen, thymus, and seminal vesicles.
The following tissues were collected from at least 20 control, low-, mid-, and high-dose P 1 and F 1 rats at necropsy: vagina, uterus, ovaries with oviducts, cervix, stomach, pituitary, testes, epididymides (left, total, and left caudal), prostate, brain, liver, kidneys, adrenal, spleen, thymus, and seminal vesicles with coagulating glands. In addition, any gross lesions noted at necropsy were collected. All collected tissues were xed in 10% neutralbuffered formalin except testes, which were xed in Bouin's solution. The vagina, uterus, ovaries and oviducts, cervix, testes, prostate, and seminal vesicles of 20 randomly selected rats, in the control and high-dose groups from each generation, were examined using light microscopy by a veterinary pathologist. In addition, histopathologic evaluation was conducted on the spleen, thymus, liver, and kidneys from 10 randomly selected rats/sex in the control and high-dose groups of both generations.
Male Reproductive Function Assessment
After the mating phase of the study, the right testis and epididymis of at least 20 males per group in the P 1 and F 1 generations were removed, trimmed of excess fat, and weighed. These organs were held at 37 ± C to preserve sperm motility. At least two pinhead-sized samples of sperm were collected from the right caudal epididymis at the origin of the vas deferens. Each sample was mixed with test yolk buffer (consisting of denatured chicken egg yolk in a glucose/skim milk supplemented physiological buffer) and a video recording was made for evaluation of motility using an Olympus BH-2 series scope with a heated stage and video attachment (Javalin CCTV camera with ultra high resolution CCD [Javalin Electronics, Los Angeles, CA], VHS standard 4-head VCR, and a Zenith 20 00 TV/Monitor [Zenith Radio Corp, Glenview, IL]). Five elds from the two samples were recorded for assessment of total and progressive motility. Evaluation of the videotaped motility was performed in the control and high-dose group.
After the motility evaluation, the caudal epididymis was weighed and then macerated in phosphate-buffere d saline (PBS). This preparation was used for sperm count analyses (all groups) and sperm morphology evaluation. For sperm morphology an aliquot of the macerated caudal epididymis was stained with eosin Y, and four slides were prepared for evaluation. Sperm morphology consisted of microscopic evaluation of two hundred sperm/rat in the control and high-dose groups.
Homogenization resistant sperm were evaluated from the right testis in the control and high-dose groups on the day of collection, whereas the testes from the lower-dose groups were frozen at ¡70 ± C for possible future processing. The methodology was modeled after Blazak, Treinen, and Juniewicz (1993) and consisted of removal of the tunica albuginea and weighing the parenchyma of the testis. The parenchyma was then minced, the contents transferred to a homogenizing vessel, and the tissue homogenized for approximately 2 minutes in 50 ml of Saline-Merthiolate-Triton (SMT). Testicular sperm counts were determined in the control and high-dose groups for both generations and in the mid-dose group of the F 1 generation.
Statistical Procedures
Body weight, body weight gain, litter weight, litter survival, water and food consumption, and organ weight data, organ-tobody weight ratios, male reproductive function, female cyclicity, developmental landmarks, clinical pathology, and immunotoxicity data were evaluated by analysis of variance (ANOVA; ® D 0:05) followed, where appropriate, by Dunnett's test (® D 0:05), mating indices (e.g., percent mated) were analyzed by chi-square or Fisher Exact test. The statistical packages used were LABCAT or SYSTAT (SPSS, Inc., Chicago, IL, version 5.0).
RESULTS
Phenol Formulations Analysis
Chemical analysis con rmed the stability of the phenol in drinking water for at least 14 days under the conditions of use in this study (data not shown). Analyses of samples of the test water (all three dose levels) prepared during weeks 1, 3, 4, 7, 15, 24, and 33 showed that the mean concentrations in the water supplied to the animals was within 1.5% of target levels. No phenol was detected in any control drinking water at any time during the study.
The average daily intake of phenol for parental males during week 10 of exposure was calculated to be 0, 14.7, 70.9, and 301.0 mg/kg/day, whereas P 1 female intake was 0, 20.0, 93.0, and 320.5 mg/kg/day for the control, low-, mid-and high-dose groups, respectively. Average daily intake during week 10 was 0, 13.5, 69.8, and 318.1 mg/kg/day for F 1 males and 0, 20.9, 93.8, and 379.5 mg/kg/day for the F 1 females at the same dose levels. As indicated in Table 1 , the average daily intake of phenol on a mg/kg basis was higher in weanlings compared to the average intake of an adult animal. 
Clinical Observations and Mortality
Three parental male rats (one control and two high-dose rats) died during the study; their deaths were not considered treatment-related (one control died spontaneously prior to cohabitation, one high-dose rat died accidentally during bleeding, whereas the other died from a bladder infection during cohabitation). Shortly after weaning, three high-dose pups (F 1 generation weighing 27, 29, or 31 g at weaning) died; these deaths appeared to be associated with reduced acclimation (i.e., avor aversion) to the test substance in the drinking water because the animals were not drinking water. Later, three F 1 dams (one each in the control, low-and high-dose groups) died spontaneously; these deaths were not considered to be treatment-related. The control died during gestation, whereas the low-and high-dose dams died undergoing parturition; no remarkable ndings were noted at necropsy in these dams. The most prominent clinical signs consisted of discolored or wet inguinal fur and redness around the nose or eyes. These signs were noted in all groups; however, the incidence was higher in the phenol-treated rats (particularly redness around nose fur and discolored or wet inguinal fur in the F 1 weanlings). In addition, twitching was observed in one F 1 high-dose male rat on one occasion.
FIGURE 1
Average daily water consumption-P 1 sires.
Water and Food Consumption, Body Weight, and Body Weight Gain Parental Generation
Daily water consumption was signi cantly decreased throughout the study in the high-dose group (5000 ppm) relative to controls (Table 1, Figures 1 to 3) . This decrease was attributed to an aversion to the avor of phenol in the drinking water at 5000 ppm. Daily food consumption in the high-dose group was also signi cantly decreased in the P 1 generation at the onset of treatment (Table 1) and during the lactation phase of the study (P 1 females; Figure 4 ). Alterations in consumption during the lactation phase of the study re ect both maternal and offspring consumption since pups begin drinking water around postnatal day 10 and eating solid food around day 12.
Concomittant with the decreases in food and water consumption were decreases in body weight, which were detected in the high-dose rats throughout the study. These decreases achieved statistical signi cance as compared to control body weights beginning on week 4 of the study for males ( Figure 5 ) and as early as week 1 for females ( Figure 6 ). Body weight gain was signi cantly decreased in the 5000-ppm group following the rst week of treatment (Table 1) . After week 1, body weight gains
FIGURE 2
Average daily water consumption-P 1 dams (premating and gestation).
FIGURE 3
Average daily water consumption-P 1 dams/litters (lactation).
FIGURE 4
Average daily food consumption-P 1 dams/litters (lactation).
FIGURE 5
Average weekly body weights-P 1 sires.
FIGURE 6
Mean body weights-P 1 dams (premating, gestation and lactation).
approached control values, and remained similar to controls from week 2 until the end of the premating phase (Table 1) . Although body weight gain of the 5000 ppm rats approached that of the controls by week 2, the initial impact resulted in a signi cant decrease in total body weight gain at the end of the 10-week premating period as well as a signi cant reduction in absolute body weight throughout the study (Table 1) .
During gestation, maternal body weight gain was similar across all groups on gestation days 7 and 14. By gestation day 20, a signi cant decrease in body weight gain was observed in the high-dose dams, with the total gain signi cantly reduced in the 5000-ppm group at the end of gestation (data not shown). Maternal body weight gain was unaffected by treatment during the lactation phase of the study. Throughout both gestation and lactation the mean maternal body weight was signi cantly lower in the animals receiving 5000 ppm as compared to controls ( Figure 6 ).
First Generation (F 1 ) Endpoints
Preweaning Body Weight, Water and Food Consumption Offspring body weight was reduced only slightly (approximately 5%) in the 5000-ppm group as compared to controls beginning on day 0; the difference in body weight between these groups became more pronounced as treatment was continued (up to 15%-20% on postnatal days 4-14 and 30% on postnatal day 21). The decrease in offspring body weights observed in the 5000-ppm group occurred concomittantly with overt maternal toxicity, as evidenced by substantially decreased maternal body weight ( Figure 6 ). This lower maternal body weight in the 5000-ppm treatment group contributed to the lower birth weights for the F 1 offspring.
The decrease in both the maternal/litter food ( Figure 4 ) and water consumption during lactation (Figure 3) for the 5000-ppm treatment group was likely due (in part) to a decrease in consumption by the offspring. Flavor aversion to phenol was also a likely factor in the larger decrease observed in the offspring body weight of the high-dose group between days 7 and 21, because the offspring begin drinking water between days 7 and 14 (generally around day 10).
No differences in postnatal offspring body weights were detected in the low-and mid-dose groups; the average body weight of the F 1 generation pups was similar to controls at birth (on postnatal day 0) and throughout the preweaning phase of the study (postnatal day 21; Table 2) .
Postweaning Food Consumption, Body Weight, and Body Weight Gain Similar to the parental generation (P 1 ), the daily water consumption of the F 1 generation was decreased throughout the study (from weaning until termination) in the high-dose group (5000 ppm) relative to controls (data not shown). Daily food consumption in the high-dose group was also decreased during the study, particularly at the onset of treatment; however, food consumption was unaffected during gestation and lactation for the F 1 females (data not shown).
Concomittant with the decreases in water and food consumption were decreases in body weight that were observed in the high dose F 1 offspring throughout the study. F 1 body weights were decreased prior to weaning (Table 2 ) and throughout the postweaning phase (Figures 7 and 8) , including gestation and lactation ( Figure 8 ). Body weight gain was signi cantly decreased in the 5000-ppm group following the rst week of treatment;
FIGURE 7
Weekly body weights-F 1 sires. however, it approached control values after week 3 in males and week 1 in females. Although body weight gain approached controls values, total gain in males was signi cantly decreased at the end of the premating phase, whereas in females it was only reduced during gestation (data not shown).
Second Generation (F 2 ) Endpoints
F 2 Preweaning Body Weight The preweaning growth pattern of the F 2 generation was similar to the F 1 generation
FIGURE 8
Mean body weights-F 1 dams (premating, gestation, and lactation).
( Table 2 ). F 2 offspring body weight was slightly reduced in the 5000-ppm group on postnatal day 0 (7%); this decrease persisted through postnatal day 21 and its magnitude increased over time (up to 20%-28% on postnatal days 4-21). Again, decreased maternal body weight (F 1 dams) and avor aversion to phenol in the drinking water were likely signi cant factors that contributed to the decreased body weights in the high-dose F 2 offspring.
Reproductive Performance, Offspring Viability, and Developmental Landmarks
There were no signi cant differences among groups in reproductive performance in either generation (Table 3 ). The average length of gestation across all groups was approximately 22 to 22.5 days for both the P 1 and F 1 generations. The number and percent of animals, which mated, and the percent undergoing successful parturition were similar across all groups for both generations (P 1 and F 1 ).
The average number of live births/litter and percent of offspring alive on postnatal day 0 was similar for all groups and across both generations (Table 3) . However, following postnatal day 0 the survival of the high-dose (5000 ppm) offspring was adversely affected in both generations. The percent of F 1 high-dose group (P 1 offspring) surviving was signi cantly reduced on postnatal day 4. After culling, the percent survival was similar across all groups. The percent survival was similarly affected in the F 2 generation; however, survival in the high-dose group remained affected after culling and was reduced on postnatal days 7 to 21 ( Table 3 ). The decreased survival of the high-dose offspring was likely linked to the overt maternal toxicity that occurred at this dose, as indicated by the decreased maternal body weight and water consumption. Overall, percent survival was comparable between the lowand mid-phenol dose groups and the control group of each generation.
The average time to preputial separation for F 1 males was signi cantly longer in the high-dose group (47.8 days) than control group (44 days) (Table 4 and Figure 9 ). Likewise, vaginal patency in the F 1 high-dose female rats occurred signi cantly later than in the control females (38.3 and 34.6 days, respectively, Table 4 and Figure 10 ).
Immunotoxicity Screening and Clinical Pathology
No signi cant effects were detected in spleen weight, cellularity (cells/spleen), or antibody-forming cells (per spleen or per 10 6 cells) for any phenol-treated group compared to the vehicle control. As expected, there was a signi cant reduction of AFC activity, spleen cellularity, and spleen weight in the positive control (PC) exposed rats compared to the vehicle controls (Table 5) . 
FIGURE 9
Individual age at preputial separation. Clinical chemistry and hematology parameters were unaffected by phenol treatment, except for a minimal, but statistically signi cant, increase in blood urea nitrogen (BUN) in the high-dose group (5000 ppm) following 13 weeks of treatment (mean BUN values were 14 § 2.3 for the control group and 18 § 2.4 for the high-dose group; Table 5 ).
Gross Pathology, Organ Weights, and Histopathology
Signi cant decreases in absolute seminal vesicle weights were detected in the P 1 high-dose males, and decreases in absolute adrenal, brain, spleen and ovary weights were noted in the P 1 high-dose (5000 ppm) females (Table 6) . Organ-to-body weight ratios for the brain, kidneys, liver, testes, epididymides, and right testis parenchyma were signi cantly increased in the high-dose group males; these were ascribed to signi cantly lower nal body weights (Table 7) . Organ-to-body weight ratios for the brain and liver were signi cantly increased in the high-dose group P 1 females, again a result of the signi cantly lower nal body weights (Table 7) .
Various absolute organ weights were reduced in the high-dose group of the F 1 generation (males: adrenals, brain, liver, seminal vesicles, spleen, testes, epididymides, right testis parenchyma, and prostate; females: spleen and uterus). In addition, the absolute adrenal, spleen, and prostate weights of the mid-dose F 1 males were slightly decreased, whereas mid-dose females absolute liver weights were increased (Table 8 ). Relative organto-body weight ratios (Table 9) were increased in the highdose group (F 1 males: brain, kidneys, epididymides, testes, right cauda, and right testes parenchyma; F 1 females: brain, kidneys, and liver). Again, the increased organ-to-bod y weight ratios were ascribed to the reduced nal body weight.
Signi cant decreases in absolute prostate weight (reduced by approximately 15%; Table 8 and Figure 11 ) were noted in all three phenol-treated groups in the F 1 generation, but not the P 1 generation. However, relative prostate weights (Table 9) were signi cantly reduced in only the mid-dose group (1000 ppm).
Signi cant reductions in both absolute and relative uterine weights were noted in all three phenol-treated groups in the F 1 generation, but not the P 1 generation (Tables 8 and 9 , and Figure 12 ).
Microscopic examination of the reproductive organs, including accessory sex organs, failed to show any adverse treatment-related lesions in either generation. Histological examination of the uterus (control and high-dose groups in the F 1 generation) did reveal an increased incidence of uterine dilatation in the control group (7/20) compared to the high-dose group (2/20). The decreased incidence of uterine dilatation in the high-dose group may partially explain the signi cant reductions in absolute and relative uterine weights seen in the phenoltreated groups; vaginal cytology of rats with uterine dilatation indicated that the stage of the estrus cycle prior to necropsy was either proestrus or estrus because smears consisted of nucleated epithelial or corni ed epithelial cells. Based on vaginal cytology data collected just prior to necropsy, the number of F 1 rats in proestrus/estrus was similar in three of the groups (16/24 controls, 15/24 low, 13/25 mid), but was lowest in the high-dose group (9/22). No treatment-related lesions were detected in any of the other organs examined (kidneys, spleen, liver, and thymus) in the P 1 or F 1 generations.
Vaginal Cytology and Sperm Evaluations
The average frequency of the estrus cycle during the 21-day collection period ranged from 3.8 to 4.7 days and was similar in all groups for both generations; and thus it was unaffected by treatment with phenol (Table 10) . Epididymal sperm count, motility (percent motile and percent progressively motile) and sperm morphology across both generations were also unaffected by treatment (Table 10) . Testicular sperm count (homgenization resistant sperm) and production rate were unaffected in the P 1 generation; however, statistically signi cant increases in testicular sperm count and production rate (both parameters were adjusted for organ weight) were noted in the 5000-ppm group (F 1 generation) compared to controls. These increases were presumed to be associated with the reduced absolute testis weight, which was secondary to reduced body weight and therefore artifactual in nature. In an effort to fully characterize any potential adverse effect on the testis, the testicular count was extended to the mid-dose group. No difference in testicular count was noted in the mid-dose group compared to controls; therefore, the observed change in the high-dose group was ascribed to lower testis weight rather than to a true alteration in sperm count or production.
DISCUSSION
During this study, the daily intake of phenol in adult rats was calculated to be 0, 14, 70, and 310 mg/kg/day for males and 0, 20, 93, and 350 mg/kg/day for females in the control (0 ppm), low (200 ppm), mid (1000 ppm), and high (5000 ppm) dose groups, respectively in both generations. Persistent and significant reductions in water consumption, and transient effects on food consumption were observed in the 5000-ppm group of both generations. The decreased water consumption was believed to be due to the animals' aversion to the avor of phenol in the drinking water.
Reductions in body weight/body weight gain were also observed in both generations at 5000 ppm, whereas some relative organ-to-bod y weight ratios were signi cantly increased. Because there were no histological changes in the affected organs, nor any indications of organ toxicity from the clinical pathology pro les, the alterations in absolute and relative organ weights observed across both generations were considered to be secondary effects to the reduced body weights. Statistically signi cant reductions in absolute prostate and uterus weights (all three dose levels) as well as reductions in relative uterus (all treated groups) and prostate (mid-dose only) weights were noted in the F 1 generation. As illustrated in Figures 11 and 12 , only a few individual phenol-treated animals had prostate or uterus weights that were outside of the control range. Speci cally, lower prostate weights were noted in four, three, and two animals in the low-, mid-and high-dose groups, respectively, whereas, lower uterine weights were noted in two, three, and four rats for the low-, mid-and high-dose groups, respectively. Thus, it is unlikely that the decreased prostate and uterus weights represent an adverse effect of phenol treatment because (1) there was a lack of a doseresponse relationship; (2) there was an absence of any functional reproductive effects (other than the decrease in pup survival associated with decreased body weight at the high dose); (3) there was an absence of any adverse histological changes in reproductive organs; and (4) only a few animals had organ weights outside the range of concurrent control values. Further, it has recently been shown that there is a large intralitter variability in rat prostate weight and that this large variability can lead to either type I or type II errors when the sampling size for this endpoint is less than 4 males/litter (Janszen, Elswick, and Welsch 2000) . A signi cant increase in BUN was detected in the 5000-ppm group in the P 1 animals selected for immunotoxicity screening. Although statistically signi cant, this alteration was not considered biologically relevant because (1) no corresponding increase in creatinine was detected; (2) no evidence of histopathological change was observed in the kidney or liver; and (3) only one high-dose BUN value fell outside the control range (the control range values were 11-19 mg/dl, whereas the high-dose values ranged from 14 to 19 with one value of 22 mg/dl). Mating performance and fertility in both generations were similar in all phenol-treated groups relative to controls. Vaginal cytology/cyclicity and male reproductive functions epididymal/testicular sperm counts, motility, and morphology were unaffected by treatment in the P 1 rats. A statistically signicant increase in testicular sperm counts (numbers of sperm/gram testis and sperm production rate) was detected in the F 1 generation at the high dose only. This change was considered to be artifactual in nature and caused by the reduced body weight (and hence decreases in absolute but not relative testis weight) rather than an alteration in sperm production. No adverse treatmentrelated effects were observed microscopically in the testes, ovaries, uterus, prostate, or any of the other tissues examined in either generation.
Litter survival and offspring body weights (preweaning) were reduced in the 5000-ppm group across both generations; for survival, this effect was more pronounce d in the F 2 generation. The adverse affect on survival and offspring body weight was observed in the presence of overt maternal toxicity as indicated by the decreased maternal body weight; again this maternal effect was believed to be secondary to the animals' (dam and litter) aversion to the avor of the phenol-containing drinking water and resulted in decreased maternal as well as offspring body weight (preweaning) . Alterations in body weight and water consumption continued after weaning of the 5000-ppm offspring and persisted throughout the life span of the F 1 genera-tion (5000 ppm group). Delays in vaginal patency and preputial separation accompanied the growth retardation (decreased preand postweaning body weights in the 5000-ppm group). Vaginal patency and preputial separation are developmental landmarks indicative of the onset of puberty. The onset of puberty can be delayed by several external factors, such as handling during the prenatal period (Korenbrot, Huhtaniemi, and Weiner 1977) , bedding rotation (Ramaley 1975) , light/dark cycle (Cons and Timiras 1975; Rivest et al. 1986 ), as well as nutritional (energy availability) effects (Fan et al. 1997; Parshad 1990; Park et al. 1994; Cunningham, Clifton, and Steiner 1999; Cheung et al. 1997; Carney, Scortichini, and Crissman 1998) . Thus, the delay in these landmarks seen only at the top concentration was attributed to the decreased water (preand postweaning) and food (preweaning) consumption, and corresponding reduction in growth rate (reduced body weight) caused by avor aversion to phenol in the drinking water. Hsieh et al. (1992) saw evidence of immunotoxicity in phenoltreated CD-1 mice. No such toxicity was seen in this study using rats. Phenol did not alter any of the parameters used to evaluate immunotoxicity under the conditions of this study (higher doses, in rats, longer duration and larger group size). Finally unlike Berman et al. (1995) , no target organ toxicity was detected in the liver or kidneys, nor was organ toxicity observed in the thymus or spleen. The lack of organ toxicity in this study compared to Berman may be associated with (1) the route of exposure (drinking water vs. bolus gavage administration); and (2) possible differences in the strain of rat used (this study was conducted using Sprague-Dawley rats, whereas Berman used F344 rats). The effects (decreased body weight/body weight gain, decreased water and food consumption, reduced litter survival, decreased offspring body weight/growth delay, increased organto-body weight ratios, and delays in landmarks of sexual maturation) were considered secondary to avor aversion to phenol in the drinking water and water avoidance at 5000 ppm. The results of this study con rm and extend those of Heller and Pursell (1938) who reported no functional reproductive effects of phenol at concentrations up to 5000 ppm in drinking water. Based on a comprehensive examination of all parameters (and speci cally based on decreased pup survival at the 5000-ppm concentration that may be related to avor aversion), the noobservable-adverse-effect level (NOAEL) of phenol in drinking water is 1000 ppm. The corresponding daily intake of phenol for an adult rat at the NOAEL of 1000 ppm is equivalent to about 70 mg/kg/day for males and 93 mg/kg/day for females. 
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